Research Solutions, Inc. (NASDAQ:RSSS – Get Free Report) major shareholder Peter Derycz sold 18,000 shares of the stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $2.34, for a total transaction of $42,120.00. Following the transaction, the insider now owns 3,303,322 shares in the company, valued at $7,729,773.48. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Research Solutions Price Performance
Research Solutions stock opened at $2.31 on Thursday. Research Solutions, Inc. has a 12-month low of $1.80 and a 12-month high of $2.65. The company has a market capitalization of $68.42 million, a price-to-earnings ratio of -77.00 and a beta of 0.54. The firm’s fifty day moving average price is $2.35 and its 200 day moving average price is $2.20.
Research Solutions (NASDAQ:RSSS – Get Free Report) last posted its quarterly earnings data on Wednesday, September 13th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. The firm had revenue of $9.96 million for the quarter, compared to the consensus estimate of $9.70 million. Research Solutions had a negative net margin of 1.61% and a negative return on equity of 9.77%. During the same period in the prior year, the firm posted ($0.02) EPS. Analysts forecast that Research Solutions, Inc. will post -0.08 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Research Solutions
Analyst Ratings Changes
Several equities analysts recently weighed in on RSSS shares. Roth Mkm restated a “buy” rating and set a $4.35 target price on shares of Research Solutions in a report on Thursday, September 14th. Maxim Group reiterated a “buy” rating and issued a $5.00 target price on shares of Research Solutions in a research note on Thursday, September 14th.
Research Solutions Company Profile
Research Solutions, Inc, through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle.
- Five stocks we like better than Research Solutions
- Investing in Blue-Chip Stocks
- Buffett’s latest portfolio additions, trims, and cuts in Q3
- How to Invest in Biotech Stocks
- 5 reasons TJX Companies will hit new highs in 2024
- How to Invest in E-Commerce: A Guide
- Game-changing news for Ambarella puts the market in reversal
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.